Speaker

Dr. Sofie Gustafsson is the Global Director of RWE Partnerships and Innovation for International Developed Markets at Pfizer, leading strategic data collaborations for real-world evidence studies across all therapeutic areas. She is an affiliated researcher at the Karolinska Institute, a licensed pharmacist, and holds a PhD in economics. Internationally, Dr. Gustafsson has contributed to initiatives such as the International Horizon Scanning Initiative (IHSI), several IMI/IHI consortiums, and Nordic collaborations such as the Nordic Pharmaceutical Forum. Previously, at Sweden’s HTA agency TLV, she led several governmental assignments on the data access and methodologies for use in HTA decision-making and developed value-based pricing frameworks for therapies targeting rare diseases.